Crescenta is currently managed by its founders, key scientific advisers, and the director of Akoyat, A.S., its primary investment firm.
Emre Koyuncu, Ph.D. - Founder & CEO
Dr. Koyuncu has a track record of innovative discoveries in both academia and biotech. The IP he developed at Princeton University formed a basis of several startups and was licensed/optioned by companies including Kadmon and Merck. (PhD in Molecular Biology & Virology, Heinrich-Pette-Institut, Hamburg; postdoc, Shenk Lab, Princeton University.)
Hahn Kim, Ph.D. - Founder
Founding director of Princeton University Small Molecule Screening Center. As a co-founder of Chiromics, a Princeton startup, his role was instrumental in Chiromics’ successful collaborations with leading pharma companies such as Pfizer, Merck, GSK and Genentech. (PhD in Organic Chemistry, Princeton University; postdoc, MacMillan Lab, Princeton University.)
Gökhan Hotamışlıgil, MD, PhD.
J.S. Simmons Professor of Genetics and Metabolism and Chair of the Department of Genetics and Complex Diseases at Harvard T.H. Chan School of Public Health. An internationally recognized leader in the area of metabolic diseases. His research has pioneered the emergence of immunometabolism as a new field and identified central mechanisms of metabolic diseases. (MD, Ankara University; PhD, Harvard University; postdoc, Spiegelman Lab, Harvard University.)
Patrick Lam, Ph.D. - Adviser
Former Director of the Discovery Chemistry Department at Bristol-Myers Squibb. Co-inventor of a total of eight clinical candidates and the blockbuster anticoagulant drug Eliquis®/Apixaban (PhD in Organic Chemistry, University of Rochester; postdoc, Jung lab, UCLA)
Lynn Enquist, Ph.D. - Adviser
Henry L. Hillman Professor of Molecular Biology and the Princeton Neuroscience Institute. A world-renowned leader in the area of molecular biology & virology with years of pharma experience in companies such as Du Pont and Du Pont-Merck. (PhD in Microbiology, Medical College of Virginia; postdoc, Skalka lab, Roche Institute of Mol. Bio.)
Crescenta Biosciences is proud to announce a seed-funding partnership with Akoyat, A.S., an investment company located in Istanbul, Turkey.
Crescenta is actively seeking additional interested investors. Please contact us if you would like to discuss the investment opportunities available at this phase of Crescenta's development.
Crescenta is actively expanding our team. We are hiring highly creative, motivated, and intelligent scientists and managers for positions at all levels. While there are no open posted positions at this time, please check for updates to this space for specific postings in the future.
If you believe that you may be a great fit for Crescenta, we invite you to contact email@example.com for employment-related information.